Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome

NCT03148444 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Infection, Bacterial
Pacemaker Complication

Interventions

DRUG: cefalexin 500 mg qid or roxithromycin 150 mg bid

Sponsor

Kaplan Medical Center